Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K1UR
|
|||
Former ID |
DNC012665
|
|||
Drug Name |
4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL118682; SCHEMBL4811439
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H26N2
|
|||
Canonical SMILES |
CCCC(CCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C22H26N2/c1-3-8-20(9-4-2)22-23-16-21(24-22)19-14-12-18(13-15-19)17-10-6-5-7-11-17/h5-7,10-16,20H,3-4,8-9H2,1-2H3,(H,23,24)
|
|||
InChIKey |
VAJCFLBVVHOAAW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium channel unspecific (NaC) | Target Info | Inhibitor | [1] |
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Dopaminergic synapse | |||
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.